Huge Differences in Clinton and Trump Health Care Proposals

The health care reform plans proposed by Hillary Clinton would add boost coverage to as many as 9.6 million more Americans, while under Donald Trump’s proposal, as many as 25 million people would lose coverage, according to a new analysis.

Clinton and Trump have vastly different ideas for how they would change the health care system. While discussions on health care have been largely absent from the campaign trail, Clinton has said she would want to tinker with the Affordable Care Act – the health reform law signed by President Obama – Trump has said he would scrap Obamacare all together.

Researchers at the RAND Corp. made their determinations by analyzing various proposals made by the candidates so far this year. The report was conducted by RAND for the non-partisan Commonwealth Fund.

The researchers also found that the candidates’ plans would have dramatically different effects on health plan out-of-pocket costs. Clinton’s proposals reduce those costs for some people who get their insurance through the online state health insurance exchange by as much as one-third. Meanwhile, Trump’s proposals would increase out-of-pocket costs for these customers on the individual insurance market by between $300 to $2,500.

Incidentally, the average out-of-pocket costs for plans on the individual exchanges is $3,200. And the RAND analysis also showed that Trump’s proposal to make all insurance premiums for plans purchased on the individual market tax-deductible would actually end up lowering out-of-pocket costs for higher-income families.

Both candidates’ plans would add significantly to the national deficit. Clinton’s plans would add around $90 billion to the debt. On the other hand, Trump’s ideas would add about $41 billion to the federal deficit.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement